Zylox-Tonbridge's Bold Move with LifeTech Investment
An Investment That's Turning Heads Alright, here's a curveball for ya. Zylox-Tonbridge and GL Capital are throwing down a cool HK$1.482 billion into LifeTech Scientific, aiming for a high-stakes play in the vascular and structural heart field. This isn't just peanuts or pocket change; it's a concerted push to carve out a new landscape in China with something akin to a...
Continue Reading